Clinical trials
Uremia clinical trials
Below are recruiting uremia clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03629977Recruiting
Timing dialysis in critically ill ICU patients
This study looks at the best timing for starting kidney support treatment (dialysis) in very sick people in the ICU. It may help improve outcomes by comparing different start times.
StockholmAges 18 years+ - NCT06233838Recruiting
Hemoperfusion study for kidney patients on dialysis
This trial tests a special blood-filtering treatment (hemoperfusion) for people with advanced kidney disease on regular dialysis. It aims to remove harmful substances that standard dialysis may not fully clear.
Fuzhou, FujianAges 18 years+ - NCT06249373Recruiting
Low-intensity ultrasound to help new fistula mature
This study tests whether low-intensity ultrasound (LIPUS) can help a new arteriovenous fistula (AVF) in the wrist mature faster and work better for dialysis. It may be a good fit if you are an adult with a new fistula that hasn't been used yet.
Suzhou, JiangsuAges 18–75 - NCT07033260Recruiting
Carotid ultrasound to predict low blood pressure during dialysis
This study looks at whether an ultrasound of the carotid artery (the main artery in your neck) can help predict drops in blood pressure during dialysis. It may help doctors find people at risk for low blood pressure during treatment.
Wuhu, Outside of the USAges 18–80 - NCT07123909Recruiting
Immune adsorbent therapy for dialysis patients with inflammation
This study tests a therapy that absorbs inflammatory substances from the blood during dialysis. It may help people on dialysis who have ongoing inflammation, shown by high IL-6 or CRP levels.
MoscowAges 18 years+ - NCT07199504RecruitingPhase 2/Phase 3
Dipyridamole for restless legs syndrome in dialysis patients
This trial tests if dipyridamole, a medication that affects blood flow, can help relieve restless legs syndrome (RLS) in people on hemodialysis. It may offer a new treatment option for RS related to kidney failure.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT07522008Recruiting
Testing a blood-cleaning add-on for dialysis symptom relief
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
Cagliari, ItalyAges 18 years+
Hear when a new Uremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for uremia?
- Yes. Clin2 currently lists 7 recruiting uremia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a uremia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a uremia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.